← Back to Search

Team Approach vs Peer Support for Dual Diagnosis (STAR-LS Trial)

N/A
Recruiting
Led By David Smelson, PsyD
Research Sponsored by University of Massachusetts, Worcester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 9-months
Awards & highlights

STAR-LS Trial Summary

This trial will evaluate if a team approach for people with co-occurring mental health and substance use disorders helps improve outcomes more than just linking with a Peer Specialist.

Who is the study for?
This trial is for adults over 18 with co-occurring substance use and mental health disorders, not currently engaged in similar treatments or haven't seen their provider in 3 months. It's not for those who are acutely psychotic or suicidal with a plan, homicidal, have severe alcohol use disorder, or need high dose benzodiazepine detoxification.Check my eligibility
What is being tested?
The study compares MISSION (a comprehensive team-based approach) to just getting linked up by a Peer Specialist for people with substance and mental health issues. The goal is to see which method better improves treatment engagement and health outcomes.See study design
What are the potential side effects?
Since this trial focuses on service delivery methods rather than medications, it does not list specific side effects like drug trials do. However, participants may experience varying levels of emotional discomfort during the recovery process.

STAR-LS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~9-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 9-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability & Appropriateness
Alcohol or other drug 12-Step Participation
Baseline Demographics
+16 more

STAR-LS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Full MISSIONExperimental Treatment1 Intervention
Participants assigned to this condition will receive full MISSION services. MISSION services include 6-months of integrated mental health and substance use treatment and treatment planning with the MISSION Case Manager (13 session curriculum) and Peer Support Specialist (11 session curriculum). Content of these sessions will be directed using the MISSION Treatment Manual and Consumer Workbooks. MISSION teams will also provide linkages and supports to treatment services within the participant's community throughout the duration of the study.
Group II: Linkage Only Delivered by a Peer SpecialistActive Control1 Intervention
Our Linkage only arm delivered by a Peer Specialist will act as the comparison group to the MISSION arm. Participants randomized to the linkage only arm will receive 6-months of linkage care from a Peer Specialist. The Peer Specialist will provide informal treatment planning as well as linkages and support to community services, but will not provide integrated dual disorders treatment, nor will this arm utilize any MISSION materials or offer Peer led groups.

Find a Location

Who is running the clinical trial?

Centers for Disease Control and PreventionFED
875 Previous Clinical Trials
22,477,194 Total Patients Enrolled
1 Trials studying Mental Health Disorders
176 Patients Enrolled for Mental Health Disorders
University of Massachusetts, WorcesterLead Sponsor
343 Previous Clinical Trials
986,402 Total Patients Enrolled
1 Trials studying Mental Health Disorders
1,000 Patients Enrolled for Mental Health Disorders
University of Massachusetts, LowellOTHER
20 Previous Clinical Trials
10,101 Total Patients Enrolled
1 Trials studying Mental Health Disorders
1,000 Patients Enrolled for Mental Health Disorders

Media Library

Full MISSION Clinical Trial Eligibility Overview. Trial Name: NCT05713695 — N/A
Mental Health Disorders Research Study Groups: Full MISSION, Linkage Only Delivered by a Peer Specialist
Mental Health Disorders Clinical Trial 2023: Full MISSION Highlights & Side Effects. Trial Name: NCT05713695 — N/A
Full MISSION 2023 Treatment Timeline for Medical Study. Trial Name: NCT05713695 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities for individuals to enroll in this research study?

"According to the most recent data on clinicaltrials.gov, this research is currently seeking participants. This medical trial was first posted on May 25th 2023 and its records were updated in mid-May of that same year."

Answered by AI

How many participants are currently recruited into this clinical research?

"Affirmative. Clinicaltrials.gov's records demonstrate that this research is presently recruiting volunteers, which was first made public on May 25th 2023 and last updated on the 15th of the same month. A total of 208 participants are being welcomed from a single medical centre."

Answered by AI

Who else is applying?

What site did they apply to?
University of Massachusetts Medical School
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Supporting Treatment Access and Recovery Through Linkage and Support
David Smelson 2023. "Supporting Treatment Access and Recovery Through Linkage and Support". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05713695.
~113 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top